Synteny logo — Decoding biology to end disease.

Synteny

Decoding biology to end disease.

Founded 2022 United Kingdom United Kingdom 21 employees Series A Total: $1.75M

General Information

Company Name Synteny
Founded Year 2022
Location United Kingdom United Kingdom
Employees 21
Funding Stage Series A
Business Model B2B, Platform, SaaS
Revenue Model Subscription, Licensing, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Synteny. To contact Synteny, visit synteny.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Synteny

Synteny is a biotechnology company based in the United Kingdom. It provides AI-driven biological cognition solutions to biotech companies, pharmaceutical industries, research institutions, and healthcare organizations.

Founded in 2022, Synteny specializes in molecular recognition and biological data decoding. Operating on a B2B model, the company offers its platform as a Software-as-a-Service (SaaS). Its revenue is generated through subscription, licensing, and usage-based models.

Taxonomy: biological data foundry, molecular recognition, disease prevention, AI in biology, biotechnology innovation, genomics, bioinformatics, healthtech, molecular biology, precision medicine, computational biology, biological data analysis

Services & Products

Molecular recognition transformation
Biological data decoding
AI-driven biological cognition solutions

Target Customers

Biotech companies Pharmaceutical industries Research institutions Healthcare organizations

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A £1.75M 4
Amplifyher Ventures, Obvious Ventures +2
01 Oct 2023
Seed Undisclosed -
01 May 2023
Seed Undisclosed 1
Green D Ventures
01 Jan 2022

Synteny Alternatives & Competitors

View All Alternatives
Synteny vs

We build foundation models that will transform biology.

Series A
44 employees
Biotechnology, Pharmaceutical
Synteny vs
Viome Life Sciences
Viome Life Sciences United States

We're on a mission to decode human biology in order to prevent and reverse chronic diseases, cancers...

Venture round
30 employees
Health Care
Synteny vs
InnoSIGN
InnoSIGN The Netherlands

Comprehensive Pathway Analysis

Series A
5 employees
Biotechnology, Life Sciences

FAQ About Synteny

Decoding biology to end disease.
Synteny was founded in 2022.
Synteny is headquartered in United Kingdom.
Synteny has a B2B, Platform and SaaS business model. Its revenue comes from Subscription, Licensing and Usage Based.
Synteny has approximately 21 employees.
Synteny has completed 3 funding rounds, raising a total of $1.75M. The latest funding stage is Series A.
Synteny offers: Molecular recognition transformation, Biological data decoding, AI-driven biological cognition solutions.
Top alternatives and competitors to Synteny include Bioptimus, Viome Life Sciences, InnoSIGN, Tahoe Therapeutics, Diffuse Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Synteny and Bioptimus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Synteny, https://bouncewatch.com/company/synteny, updated 29 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes